Canopy Growth Corp stock has seen a dip this week amidst ongoing developments in its business strategy.
Canopy Growth Corp (WEED.TO) has experienced a decline of 3.03% over the past week, closing at C$1.30. This performance comes in the context of various company announcements and broader market trends in the health care sector.
Investor takeaway: Investors should keep an eye on Canopy Growth's ongoing efforts to solidify its position in the medical cannabis market, particularly in Australia, while being mindful of its financial metrics and market conditions.
Advertisement
Canopy Growth Corp
WEED.TO
WEED.TO
Canopy Growth Corp
WealthAwesomeMarket cap
$575.10M
52W high
$3.28
52W low
$1.18
1W change
-3.03%
Beta
2.43
Analyst Price Targets
Based on analyst covering WEED · as of Sep 17, 2026
Wall Street analysts forecast WEED stock price to rise 57.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.02
+57.8% Upside
Current Price
C$1.28
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WEED's historical volatility
30-Day Vol
35.0%
Annualized
90-Day Vol
39.2%
Annualized
Trend (90d)
-24.9%
Annualized drift
90d Mean
C$1.20
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.27 | C$1.13 – C$1.43 |
| 60 trading days | C$1.23 | C$1.04 – C$1.46 |
| 90 trading days | C$1.20 | C$0.97 – C$1.48 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
C$1.30 Close with 3.03% Weekly Decline
Canopy Growth's stock has fallen 21.95% year-to-date, reflecting ongoing struggles in the cannabis market despite recent positive developments.
Bull case
The company reported a 13% growth in net revenue for Q1 FY2027, showing positive momentum across its business segments. The renewed EU GMP certification for its Kincardine facility could strengthen its presence in the European market.
Bear case
Despite the revenue growth, Canopy Growth faces significant challenges, including a profit margin of -79.2% and a negative return on equity of -39.5%. The stock's beta of 2.43 indicates higher volatility, which might concern risk-averse investors.
Price Action Overview
Canopy Growth Corp's stock closed at C$1.30, reflecting a 0.78% decline for the day and a notable 3.03% drop for the week. Year-to-date, the stock has decreased by 21.95%, indicating a challenging environment for the company amidst evolving market conditions.
Advertisement
Recent Company Developments
This week, Canopy Growth focused on reminding shareholders about the importance of voting ahead of the September 23 deadline for its annual general and special meeting. Additionally, the company expanded its Australian medical cannabis portfolio with new product formats and formulations, which could enhance its competitive position in that market. The Kincardine facility has also secured renewed EU GMP certification, potentially aiding in the growth of its European medical cannabis business.
Technical Picture
From a technical perspective, Canopy Growth's stock is currently trading below its 50-day moving average of C$1.35 and its 200-day moving average of C$1.50, indicating a downward trend. The stock's 52-week range has been between C$1.18 and C$3.28, with only 6% of this range being utilized. The current volume is 176,824 shares, significantly below the 20-day average of 664,297 shares, suggesting reduced trading activity.
Insider Activity
No recent insider activity has been reported for Canopy Growth Corp, which may suggest stability in management and ownership during this period of stock price fluctuation.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
